[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fDy7RX6U2vbqKSPQ8LTN7Kmg5Wa6x26k2ZK15BRQ4WU4":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":75,"rows":82},"Mount Sinai Hospital, Canada",[4],153,false,29,18,44867,13,95,[14,17,20,22,25,28,30,32],{"name":15,"count":16},"Type 2 Diabetes",8,{"name":18,"count":19},"Inflammatory Bowel Diseases",6,{"name":21,"count":19},"Crohn Disease",{"name":23,"count":24},"Ulcerative Colitis",5,{"name":26,"count":27},"Infertility",4,{"name":29,"count":27},"Influenza",{"name":31,"count":27},"Premature Birth",{"name":33,"count":27},"Pain",[35,40,45,50,55,60,65,70],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT07046572","Methoxyflurane for IUD Insertion and Endometrial Biopsy","2025-12-01","Methoxyflurane - Penthrox",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT06792214","Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD\u002FRemdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial","2026-01","Nirmatrelvir\u002Fritonavir",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT05347238","Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis","2026-06-30","Dopamine",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT05953766","Presacral Nerve Block Versus Sham Block on Post-operative Pain for Total Laparoscopic Hysterectomy","2026-07","Ropivacaine",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT05340582","Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants","2027-01","Acetaminophen",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT06042387","Genome Analysis Across Populations in Inflammatory Bowel Disease","2027-05","Blood or saliva sample collection",{"nctId":66,"briefTitle":67,"date":68,"intervention":69},"NCT06004739","Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection","2027-09","Start Antibiotics \u002F Continue Antibiotics for treatment of bacteriuria",{"nctId":71,"briefTitle":72,"date":73,"intervention":74},"NCT07294950","Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination","2028-09","Gradual dose reduction of semaglutide",[76,77,78,79,80,81],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[83,108,126,152,170,215,238,256,274,299,317,337,358,381,419,457,493,518,542,568,593,617,635,662,680,706,733,751,769,795,813,837,855,873,898,924,942,960,985,1010,1036,1054,1087,1113,1137,1163,1190,1208,1226,1244,1268,1293,1311,1336,1361,1379,1405,1423,1447,1473,1507,1538,1575,1599,1617,1643,1661,1679,1697,1721,1746,1773,1791,1815,1833,1851,1875,1901],{"intervention":44,"totalTrials":84,"cells":85},1,{"EARLY_PHASE1":86,"PHASE1":89,"PHASE2":91,"PHASE3":93,"PHASE4":95,"NA":106},{"trials":87,"activeCount":88},[],0,{"trials":90,"activeCount":88},[],{"trials":92,"activeCount":88},[],{"trials":94,"activeCount":88},[],{"trials":96,"activeCount":84,"soonestReadout":43},[97],{"nctId":41,"briefTitle":42,"status":98,"phases":99,"primaryCompletion":43,"completion":58,"start":100,"enrollment":101,"conditions":102,"interventions":104},"RECRUITING",[80],"2025-01-03",118,[103],"SARS CoV-2 Post-Acute Sequelae",[44,105],"Remdesivir",{"trials":107,"activeCount":88},[],{"intervention":105,"totalTrials":84,"cells":109},{"EARLY_PHASE1":110,"PHASE1":112,"PHASE2":114,"PHASE3":116,"PHASE4":118,"NA":124},{"trials":111,"activeCount":88},[],{"trials":113,"activeCount":88},[],{"trials":115,"activeCount":88},[],{"trials":117,"activeCount":88},[],{"trials":119,"activeCount":84,"soonestReadout":43},[120],{"nctId":41,"briefTitle":42,"status":98,"phases":121,"primaryCompletion":43,"completion":58,"start":100,"enrollment":101,"conditions":122,"interventions":123},[80],[103],[44,105],{"trials":125,"activeCount":88},[],{"intervention":74,"totalTrials":84,"cells":127},{"EARLY_PHASE1":128,"PHASE1":130,"PHASE2":132,"PHASE3":134,"PHASE4":148,"NA":150},{"trials":129,"activeCount":88},[],{"trials":131,"activeCount":88},[],{"trials":133,"activeCount":88},[],{"trials":135,"activeCount":84,"soonestReadout":73},[136],{"nctId":71,"briefTitle":72,"status":98,"phases":137,"primaryCompletion":73,"completion":138,"start":139,"enrollment":140,"conditions":141,"interventions":146},[79],"2029-05","2026-02-01",98,[142,143,144,145],"Obesity (Disorder)","Weight Change","Blood Pressure Monitoring","Appetite Regulation",[74,147],"Abrupt cessation of semaglutide",{"trials":149,"activeCount":88},[],{"trials":151,"activeCount":88},[],{"intervention":147,"totalTrials":84,"cells":153},{"EARLY_PHASE1":154,"PHASE1":156,"PHASE2":158,"PHASE3":160,"PHASE4":166,"NA":168},{"trials":155,"activeCount":88},[],{"trials":157,"activeCount":88},[],{"trials":159,"activeCount":88},[],{"trials":161,"activeCount":84,"soonestReadout":73},[162],{"nctId":71,"briefTitle":72,"status":98,"phases":163,"primaryCompletion":73,"completion":138,"start":139,"enrollment":140,"conditions":164,"interventions":165},[79],[142,143,144,145],[74,147],{"trials":167,"activeCount":88},[],{"trials":169,"activeCount":88},[],{"intervention":171,"totalTrials":172,"cells":173},"Normal saline",3,{"EARLY_PHASE1":174,"PHASE1":176,"PHASE2":178,"PHASE3":187,"PHASE4":211,"NA":213},{"trials":175,"activeCount":88},[],{"trials":177,"activeCount":88},[],{"trials":179,"activeCount":84,"soonestReadout":53},[180],{"nctId":51,"briefTitle":52,"status":98,"phases":181,"primaryCompletion":53,"completion":53,"start":182,"enrollment":183,"conditions":184,"interventions":186},[78],"2025-09-24",60,[185],"Post-operative Pain",[54,171],{"trials":188,"activeCount":88},[189,200],{"nctId":190,"briefTitle":191,"status":192,"phases":193,"primaryCompletion":194,"completion":194,"start":195,"enrollment":16,"conditions":196,"interventions":198},"NCT06590870","Intranasal Fentanyl in Preterm Infants Undergoing Peripherally Inserted Central Catheter Placement","COMPLETED",[79],"2025-02-09","2024-08-09",[197],"Procedural Pain",[199,171],"Fentanyl",{"nctId":201,"briefTitle":202,"status":192,"phases":203,"primaryCompletion":204,"completion":205,"start":206,"enrollment":207,"conditions":208,"interventions":209},"NCT01001325","Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?",[79],"2010-03","2010-07","2009-10",468,[29],[210,171],"Fluviral influenza vaccine, 2009-2010",{"trials":212,"activeCount":88},[],{"trials":214,"activeCount":88},[],{"intervention":59,"totalTrials":84,"cells":216},{"EARLY_PHASE1":217,"PHASE1":219,"PHASE2":221,"PHASE3":232,"PHASE4":234,"NA":236},{"trials":218,"activeCount":88},[],{"trials":220,"activeCount":88},[],{"trials":222,"activeCount":84,"soonestReadout":58},[223],{"nctId":56,"briefTitle":57,"status":98,"phases":224,"primaryCompletion":58,"completion":225,"start":226,"enrollment":227,"conditions":228,"interventions":230},[78],"2027-04","2022-12-12",310,[229],"Patent Ductus Arteriosus After Premature Birth",[59,231],"Ibuprofen 20 mg\u002FmL oral suspension or Ibuprofen lysine 10 mg\u002FmL injection solution",{"trials":233,"activeCount":88},[],{"trials":235,"activeCount":88},[],{"trials":237,"activeCount":88},[],{"intervention":231,"totalTrials":84,"cells":239},{"EARLY_PHASE1":240,"PHASE1":242,"PHASE2":244,"PHASE3":250,"PHASE4":252,"NA":254},{"trials":241,"activeCount":88},[],{"trials":243,"activeCount":88},[],{"trials":245,"activeCount":84,"soonestReadout":58},[246],{"nctId":56,"briefTitle":57,"status":98,"phases":247,"primaryCompletion":58,"completion":225,"start":226,"enrollment":227,"conditions":248,"interventions":249},[78],[229],[59,231],{"trials":251,"activeCount":88},[],{"trials":253,"activeCount":88},[],{"trials":255,"activeCount":88},[],{"intervention":54,"totalTrials":84,"cells":257},{"EARLY_PHASE1":258,"PHASE1":260,"PHASE2":262,"PHASE3":268,"PHASE4":270,"NA":272},{"trials":259,"activeCount":88},[],{"trials":261,"activeCount":88},[],{"trials":263,"activeCount":84,"soonestReadout":53},[264],{"nctId":51,"briefTitle":52,"status":98,"phases":265,"primaryCompletion":53,"completion":53,"start":182,"enrollment":183,"conditions":266,"interventions":267},[78],[185],[54,171],{"trials":269,"activeCount":88},[],{"trials":271,"activeCount":88},[],{"trials":273,"activeCount":88},[],{"intervention":49,"totalTrials":84,"cells":275},{"EARLY_PHASE1":276,"PHASE1":278,"PHASE2":280,"PHASE3":282,"PHASE4":284,"NA":286},{"trials":277,"activeCount":88},[],{"trials":279,"activeCount":88},[],{"trials":281,"activeCount":88},[],{"trials":283,"activeCount":88},[],{"trials":285,"activeCount":88},[],{"trials":287,"activeCount":84,"soonestReadout":48},[288],{"nctId":46,"briefTitle":47,"status":98,"phases":289,"primaryCompletion":48,"completion":290,"start":291,"enrollment":292,"conditions":293,"interventions":297},[],"2027-03-31","2023-02-06",550,[294,295,296],"Late-Onset Neonatal Sepsis","Extreme Prematurity","Neonatal Hypotension",[49,298],"Norepinephrine",{"intervention":298,"totalTrials":84,"cells":300},{"EARLY_PHASE1":301,"PHASE1":303,"PHASE2":305,"PHASE3":307,"PHASE4":309,"NA":311},{"trials":302,"activeCount":88},[],{"trials":304,"activeCount":88},[],{"trials":306,"activeCount":88},[],{"trials":308,"activeCount":88},[],{"trials":310,"activeCount":88},[],{"trials":312,"activeCount":84,"soonestReadout":48},[313],{"nctId":46,"briefTitle":47,"status":98,"phases":314,"primaryCompletion":48,"completion":290,"start":291,"enrollment":292,"conditions":315,"interventions":316},[],[294,295,296],[49,298],{"intervention":69,"totalTrials":84,"cells":318},{"EARLY_PHASE1":319,"PHASE1":321,"PHASE2":323,"PHASE3":325,"PHASE4":327,"NA":329},{"trials":320,"activeCount":88},[],{"trials":322,"activeCount":88},[],{"trials":324,"activeCount":88},[],{"trials":326,"activeCount":88},[],{"trials":328,"activeCount":88},[],{"trials":330,"activeCount":84,"soonestReadout":68},[331],{"nctId":66,"briefTitle":67,"status":98,"phases":332,"primaryCompletion":68,"completion":68,"start":333,"enrollment":292,"conditions":334,"interventions":336},[81],"2024-05-18",[335],"Infectious Disease",[69],{"intervention":64,"totalTrials":84,"cells":338},{"EARLY_PHASE1":339,"PHASE1":341,"PHASE2":343,"PHASE3":345,"PHASE4":347,"NA":349},{"trials":340,"activeCount":88},[],{"trials":342,"activeCount":88},[],{"trials":344,"activeCount":88},[],{"trials":346,"activeCount":88},[],{"trials":348,"activeCount":88},[],{"trials":350,"activeCount":84,"soonestReadout":63},[351],{"nctId":61,"briefTitle":62,"status":98,"phases":352,"primaryCompletion":63,"completion":68,"start":353,"enrollment":354,"conditions":355,"interventions":357},[],"2022-05-01",150,[23,356,21,18],"Healthy",[64],{"intervention":39,"totalTrials":84,"cells":359},{"EARLY_PHASE1":360,"PHASE1":362,"PHASE2":364,"PHASE3":366,"PHASE4":368,"NA":370},{"trials":361,"activeCount":88},[],{"trials":363,"activeCount":88},[],{"trials":365,"activeCount":88},[],{"trials":367,"activeCount":88},[],{"trials":369,"activeCount":88},[],{"trials":371,"activeCount":84,"soonestReadout":38},[372],{"nctId":36,"briefTitle":37,"status":98,"phases":373,"primaryCompletion":38,"completion":374,"start":375,"enrollment":376,"conditions":377,"interventions":380},[81],"2026-03-01","2025-07-24",174,[378,379],"Endometrial Biopsy","Intrauterine Devices",[39],{"intervention":382,"totalTrials":383,"cells":384},"letrozole",2,{"EARLY_PHASE1":385,"PHASE1":387,"PHASE2":389,"PHASE3":402,"PHASE4":404,"NA":417},{"trials":386,"activeCount":88},[],{"trials":388,"activeCount":88},[],{"trials":390,"activeCount":88},[391],{"nctId":392,"briefTitle":393,"status":192,"phases":394,"primaryCompletion":395,"completion":396,"start":397,"enrollment":398,"conditions":399,"interventions":401},"NCT01129622","Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)",[78],"2009-09","2010-09","2008-10",16,[400],"Breast Cancer",[382],{"trials":403,"activeCount":88},[],{"trials":405,"activeCount":88},[406],{"nctId":407,"briefTitle":408,"status":192,"phases":409,"primaryCompletion":410,"completion":410,"start":411,"enrollment":412,"conditions":413,"interventions":415},"NCT02703649","Administration of Single High Dose Letrozole for Ovulation Induction",[80],"2020-07-31","2016-03",36,[414],"Anovulation",[416],"Letrozole",{"trials":418,"activeCount":88},[],{"intervention":420,"totalTrials":383,"cells":421},"Tranexamic Acid",{"EARLY_PHASE1":422,"PHASE1":424,"PHASE2":426,"PHASE3":428,"PHASE4":441,"NA":455},{"trials":423,"activeCount":88},[],{"trials":425,"activeCount":88},[],{"trials":427,"activeCount":88},[],{"trials":429,"activeCount":88},[430],{"nctId":431,"briefTitle":432,"status":192,"phases":433,"primaryCompletion":434,"completion":435,"start":436,"enrollment":437,"conditions":438,"interventions":440},"NCT03565276","Tranexamic Acid for Prevention of Postpartum Haemorrhage: a Dose-finding Study",[79],"2019-03-14","2019-08-19","2018-07-11",24,[439],"Post Partum Hemorrhage",[420],{"trials":442,"activeCount":88},[443],{"nctId":444,"briefTitle":445,"status":446,"phases":447,"primaryCompletion":448,"start":449,"enrollment":450,"conditions":451,"interventions":454},"NCT02938962","Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)","UNKNOWN",[80],"2018-11","2016-10",160,[420,452,453],"Blood Loss, Surgical","Arthroplasty, Replacement, Hip",[420],{"trials":456,"activeCount":88},[],{"intervention":458,"totalTrials":383,"cells":459},"Liraglutide",{"EARLY_PHASE1":460,"PHASE1":462,"PHASE2":464,"PHASE3":466,"PHASE4":478,"NA":491},{"trials":461,"activeCount":88},[],{"trials":463,"activeCount":88},[],{"trials":465,"activeCount":88},[],{"trials":467,"activeCount":88},[468],{"nctId":469,"briefTitle":470,"status":192,"phases":471,"primaryCompletion":472,"completion":473,"start":474,"enrollment":475,"conditions":476,"interventions":477},"NCT01270789","LIraglutide and Beta-cell RepAir (LIBRA) Study",[79],"2013-12","2014-05","2011-01",63,[15],[458],{"trials":479,"activeCount":88},[480],{"nctId":481,"briefTitle":482,"status":192,"phases":483,"primaryCompletion":484,"completion":485,"start":486,"enrollment":487,"conditions":488,"interventions":490},"NCT01755572","Blood Pressure Outcomes With Liraglutide Therapy",[80],"2014-01","2014-03","2013-01",22,[15,489],"Systolic Hypertension",[458],{"trials":492,"activeCount":88},[],{"intervention":494,"totalTrials":84,"cells":495},"Bupivacaine",{"EARLY_PHASE1":496,"PHASE1":498,"PHASE2":500,"PHASE3":502,"PHASE4":504,"NA":516},{"trials":497,"activeCount":88},[],{"trials":499,"activeCount":88},[],{"trials":501,"activeCount":88},[],{"trials":503,"activeCount":88},[],{"trials":505,"activeCount":88},[506],{"nctId":507,"briefTitle":508,"status":446,"phases":509,"primaryCompletion":510,"completion":511,"start":512,"enrollment":183,"conditions":513,"interventions":515},"NCT03646006","The Effect of Pre-sacral Nerve Block on Immediate Post-operative Pain Following Laparoscopic Hysterectomy.",[80],"2019-03","2019-07","2018-08-01",[514],"Pain, Postoperative",[494],{"trials":517,"activeCount":88},[],{"intervention":519,"totalTrials":84,"cells":520},"Vaccine",{"EARLY_PHASE1":521,"PHASE1":523,"PHASE2":525,"PHASE3":527,"PHASE4":529,"NA":540},{"trials":522,"activeCount":88},[],{"trials":524,"activeCount":88},[],{"trials":526,"activeCount":88},[],{"trials":528,"activeCount":88},[],{"trials":530,"activeCount":88},[531],{"nctId":532,"briefTitle":533,"status":192,"phases":534,"primaryCompletion":535,"completion":535,"start":536,"enrollment":537,"conditions":538,"interventions":539},"NCT02263027","Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?",[80],"2016-01","2014-10",11,[29],[519],{"trials":541,"activeCount":88},[],{"intervention":543,"totalTrials":84,"cells":544},"Twinrix",{"EARLY_PHASE1":545,"PHASE1":547,"PHASE2":549,"PHASE3":551,"PHASE4":553,"NA":566},{"trials":546,"activeCount":88},[],{"trials":548,"activeCount":88},[],{"trials":550,"activeCount":88},[],{"trials":552,"activeCount":88},[],{"trials":554,"activeCount":88},[555],{"nctId":556,"briefTitle":557,"status":558,"phases":559,"primaryCompletion":560,"completion":561,"start":562,"enrollment":88,"conditions":563,"interventions":565},"NCT01126853","Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders","WITHDRAWN",[80],"2011-06","2011-07","2010-04",[564],"Hepatitis B",[543],{"trials":567,"activeCount":88},[],{"intervention":569,"totalTrials":84,"cells":570},"Preservative-free epidural morphine",{"EARLY_PHASE1":571,"PHASE1":573,"PHASE2":575,"PHASE3":577,"PHASE4":579,"NA":591},{"trials":572,"activeCount":88},[],{"trials":574,"activeCount":88},[],{"trials":576,"activeCount":88},[],{"trials":578,"activeCount":88},[],{"trials":580,"activeCount":88},[581],{"nctId":582,"briefTitle":583,"status":192,"phases":584,"primaryCompletion":585,"completion":586,"start":587,"enrollment":588,"conditions":589,"interventions":590},"NCT00803114","Epidural Morphine Following Vaginal Delivery",[80],"2004-11","2005-02","2002-03",228,[33],[569],{"trials":592,"activeCount":88},[],{"intervention":594,"totalTrials":84,"cells":595},"Buseralin",{"EARLY_PHASE1":596,"PHASE1":598,"PHASE2":600,"PHASE3":602,"PHASE4":604,"NA":615},{"trials":597,"activeCount":88},[],{"trials":599,"activeCount":88},[],{"trials":601,"activeCount":88},[],{"trials":603,"activeCount":88},[],{"trials":605,"activeCount":88},[606],{"nctId":607,"briefTitle":608,"status":192,"phases":609,"primaryCompletion":610,"completion":610,"start":411,"enrollment":611,"conditions":612,"interventions":613},"NCT02703584","Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation",[80],"2018-09",276,[26],[594,614],"pregnyl",{"trials":616,"activeCount":88},[],{"intervention":614,"totalTrials":84,"cells":618},{"EARLY_PHASE1":619,"PHASE1":621,"PHASE2":623,"PHASE3":625,"PHASE4":627,"NA":633},{"trials":620,"activeCount":88},[],{"trials":622,"activeCount":88},[],{"trials":624,"activeCount":88},[],{"trials":626,"activeCount":88},[],{"trials":628,"activeCount":88},[629],{"nctId":607,"briefTitle":608,"status":192,"phases":630,"primaryCompletion":610,"completion":610,"start":411,"enrollment":611,"conditions":631,"interventions":632},[80],[26],[594,614],{"trials":634,"activeCount":88},[],{"intervention":636,"totalTrials":84,"cells":637},"Pregnyl (1,500) IU",{"EARLY_PHASE1":638,"PHASE1":640,"PHASE2":642,"PHASE3":644,"PHASE4":646,"NA":660},{"trials":639,"activeCount":88},[],{"trials":641,"activeCount":88},[],{"trials":643,"activeCount":88},[],{"trials":645,"activeCount":88},[],{"trials":647,"activeCount":88},[648],{"nctId":649,"briefTitle":650,"status":446,"phases":651,"primaryCompletion":652,"completion":652,"start":653,"enrollment":654,"conditions":655,"interventions":658},"NCT05638529","Dual Trigger\" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome",[80],"2023-12-31","2019-05-01",80,[656,657],"Ovarian Hyperstimulation Syndrome","Infertility, Female",[636,659],"1.5 mL of normal saline",{"trials":661,"activeCount":88},[],{"intervention":659,"totalTrials":84,"cells":663},{"EARLY_PHASE1":664,"PHASE1":666,"PHASE2":668,"PHASE3":670,"PHASE4":672,"NA":678},{"trials":665,"activeCount":88},[],{"trials":667,"activeCount":88},[],{"trials":669,"activeCount":88},[],{"trials":671,"activeCount":88},[],{"trials":673,"activeCount":88},[674],{"nctId":649,"briefTitle":650,"status":446,"phases":675,"primaryCompletion":652,"completion":652,"start":653,"enrollment":654,"conditions":676,"interventions":677},[80],[656,657],[636,659],{"trials":679,"activeCount":88},[],{"intervention":681,"totalTrials":84,"cells":682},"Gabapentin",{"EARLY_PHASE1":683,"PHASE1":685,"PHASE2":687,"PHASE3":689,"PHASE4":702,"NA":704},{"trials":684,"activeCount":88},[],{"trials":686,"activeCount":88},[],{"trials":688,"activeCount":88},[],{"trials":690,"activeCount":88},[691],{"nctId":692,"briefTitle":693,"status":446,"phases":694,"primaryCompletion":695,"completion":696,"start":697,"enrollment":698,"conditions":699,"interventions":701},"NCT02999724","Gabapentin Reduces Opioid Use Postoperatively (\"GROUP Study\")",[79],"2017-09","2018-01","2017-01",44,[700],"Pelvic Organ Prolapse",[681],{"trials":703,"activeCount":88},[],{"trials":705,"activeCount":88},[],{"intervention":707,"totalTrials":84,"cells":708},"Basal insulin and exenatide",{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":713,"PHASE3":715,"PHASE4":729,"NA":731},{"trials":710,"activeCount":88},[],{"trials":712,"activeCount":88},[],{"trials":714,"activeCount":88},[],{"trials":716,"activeCount":88},[717],{"nctId":718,"briefTitle":719,"status":192,"phases":720,"primaryCompletion":721,"completion":722,"start":723,"enrollment":724,"conditions":725,"interventions":726},"NCT02194595","Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)",[79],"2021-12","2022-02","2014-09",105,[15],[707,727,728],"Basal insulin only","Basal insulin and bolus insulin",{"trials":730,"activeCount":88},[],{"trials":732,"activeCount":88},[],{"intervention":727,"totalTrials":84,"cells":734},{"EARLY_PHASE1":735,"PHASE1":737,"PHASE2":739,"PHASE3":741,"PHASE4":747,"NA":749},{"trials":736,"activeCount":88},[],{"trials":738,"activeCount":88},[],{"trials":740,"activeCount":88},[],{"trials":742,"activeCount":88},[743],{"nctId":718,"briefTitle":719,"status":192,"phases":744,"primaryCompletion":721,"completion":722,"start":723,"enrollment":724,"conditions":745,"interventions":746},[79],[15],[707,727,728],{"trials":748,"activeCount":88},[],{"trials":750,"activeCount":88},[],{"intervention":728,"totalTrials":84,"cells":752},{"EARLY_PHASE1":753,"PHASE1":755,"PHASE2":757,"PHASE3":759,"PHASE4":765,"NA":767},{"trials":754,"activeCount":88},[],{"trials":756,"activeCount":88},[],{"trials":758,"activeCount":88},[],{"trials":760,"activeCount":88},[761],{"nctId":718,"briefTitle":719,"status":192,"phases":762,"primaryCompletion":721,"completion":722,"start":723,"enrollment":724,"conditions":763,"interventions":764},[79],[15],[707,727,728],{"trials":766,"activeCount":88},[],{"trials":768,"activeCount":88},[],{"intervention":770,"totalTrials":84,"cells":771},"Desmopressin",{"EARLY_PHASE1":772,"PHASE1":774,"PHASE2":776,"PHASE3":778,"PHASE4":791,"NA":793},{"trials":773,"activeCount":88},[],{"trials":775,"activeCount":88},[],{"trials":777,"activeCount":88},[],{"trials":779,"activeCount":88},[780],{"nctId":781,"briefTitle":782,"status":783,"phases":784,"primaryCompletion":785,"completion":785,"start":786,"enrollment":27,"conditions":787,"interventions":789},"NCT02262936","Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older","TERMINATED",[78,79],"2016-02","2015-07",[788],"Nocturia",[770,790],"Fesoterodine",{"trials":792,"activeCount":88},[],{"trials":794,"activeCount":88},[],{"intervention":790,"totalTrials":84,"cells":796},{"EARLY_PHASE1":797,"PHASE1":799,"PHASE2":801,"PHASE3":803,"PHASE4":809,"NA":811},{"trials":798,"activeCount":88},[],{"trials":800,"activeCount":88},[],{"trials":802,"activeCount":88},[],{"trials":804,"activeCount":88},[805],{"nctId":781,"briefTitle":782,"status":783,"phases":806,"primaryCompletion":785,"completion":785,"start":786,"enrollment":27,"conditions":807,"interventions":808},[78,79],[788],[770,790],{"trials":810,"activeCount":88},[],{"trials":812,"activeCount":88},[],{"intervention":814,"totalTrials":84,"cells":815},"Intermittent insulin therapy",{"EARLY_PHASE1":816,"PHASE1":818,"PHASE2":820,"PHASE3":822,"PHASE4":833,"NA":835},{"trials":817,"activeCount":88},[],{"trials":819,"activeCount":88},[],{"trials":821,"activeCount":88},[],{"trials":823,"activeCount":88},[824],{"nctId":825,"briefTitle":826,"status":192,"phases":827,"primaryCompletion":828,"completion":828,"start":829,"enrollment":437,"conditions":830,"interventions":831},"NCT01755468","Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)",[79],"2017-10","2013-04",[15],[814,832],"Continuous metformin",{"trials":834,"activeCount":88},[],{"trials":836,"activeCount":88},[],{"intervention":832,"totalTrials":84,"cells":838},{"EARLY_PHASE1":839,"PHASE1":841,"PHASE2":843,"PHASE3":845,"PHASE4":851,"NA":853},{"trials":840,"activeCount":88},[],{"trials":842,"activeCount":88},[],{"trials":844,"activeCount":88},[],{"trials":846,"activeCount":88},[847],{"nctId":825,"briefTitle":826,"status":192,"phases":848,"primaryCompletion":828,"completion":828,"start":829,"enrollment":437,"conditions":849,"interventions":850},[79],[15],[814,832],{"trials":852,"activeCount":88},[],{"trials":854,"activeCount":88},[],{"intervention":199,"totalTrials":84,"cells":856},{"EARLY_PHASE1":857,"PHASE1":859,"PHASE2":861,"PHASE3":863,"PHASE4":869,"NA":871},{"trials":858,"activeCount":88},[],{"trials":860,"activeCount":88},[],{"trials":862,"activeCount":88},[],{"trials":864,"activeCount":88},[865],{"nctId":190,"briefTitle":191,"status":192,"phases":866,"primaryCompletion":194,"completion":194,"start":195,"enrollment":16,"conditions":867,"interventions":868},[79],[197],[199,171],{"trials":870,"activeCount":88},[],{"trials":872,"activeCount":88},[],{"intervention":874,"totalTrials":84,"cells":875},"Empagliflozin 10 MG",{"EARLY_PHASE1":876,"PHASE1":878,"PHASE2":880,"PHASE3":882,"PHASE4":894,"NA":896},{"trials":877,"activeCount":88},[],{"trials":879,"activeCount":88},[],{"trials":881,"activeCount":88},[],{"trials":883,"activeCount":88},[884],{"nctId":885,"briefTitle":886,"status":192,"phases":887,"primaryCompletion":888,"completion":888,"start":889,"enrollment":890,"conditions":891,"interventions":893},"NCT03215069","Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes",[79],"2024-12-31","2018-07-01",91,[892],"Gestational Diabetes",[874],{"trials":895,"activeCount":88},[],{"trials":897,"activeCount":88},[],{"intervention":899,"totalTrials":84,"cells":900},"Fluviral",{"EARLY_PHASE1":901,"PHASE1":903,"PHASE2":905,"PHASE3":907,"PHASE4":920,"NA":922},{"trials":902,"activeCount":88},[],{"trials":904,"activeCount":88},[],{"trials":906,"activeCount":88},[],{"trials":908,"activeCount":88},[909],{"nctId":910,"briefTitle":911,"status":192,"phases":912,"primaryCompletion":913,"completion":914,"start":915,"enrollment":916,"conditions":917,"interventions":918},"NCT00784784","Zanamivir Versus Trivalent Split Virus Influenza Vaccine",[79],"2009-05","2009-06","2008-11",64,[29],[899,919],"Zanamivir",{"trials":921,"activeCount":88},[],{"trials":923,"activeCount":88},[],{"intervention":919,"totalTrials":84,"cells":925},{"EARLY_PHASE1":926,"PHASE1":928,"PHASE2":930,"PHASE3":932,"PHASE4":938,"NA":940},{"trials":927,"activeCount":88},[],{"trials":929,"activeCount":88},[],{"trials":931,"activeCount":88},[],{"trials":933,"activeCount":88},[934],{"nctId":910,"briefTitle":911,"status":192,"phases":935,"primaryCompletion":913,"completion":914,"start":915,"enrollment":916,"conditions":936,"interventions":937},[79],[29],[899,919],{"trials":939,"activeCount":88},[],{"trials":941,"activeCount":88},[],{"intervention":210,"totalTrials":84,"cells":943},{"EARLY_PHASE1":944,"PHASE1":946,"PHASE2":948,"PHASE3":950,"PHASE4":956,"NA":958},{"trials":945,"activeCount":88},[],{"trials":947,"activeCount":88},[],{"trials":949,"activeCount":88},[],{"trials":951,"activeCount":88},[952],{"nctId":201,"briefTitle":202,"status":192,"phases":953,"primaryCompletion":204,"completion":205,"start":206,"enrollment":207,"conditions":954,"interventions":955},[79],[29],[210,171],{"trials":957,"activeCount":88},[],{"trials":959,"activeCount":88},[],{"intervention":961,"totalTrials":84,"cells":962},"Rellidep",{"EARLY_PHASE1":963,"PHASE1":965,"PHASE2":967,"PHASE3":969,"PHASE4":981,"NA":983},{"trials":964,"activeCount":88},[],{"trials":966,"activeCount":88},[],{"trials":968,"activeCount":88},[],{"trials":970,"activeCount":88},[971],{"nctId":972,"briefTitle":973,"status":192,"phases":974,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":978,"interventions":980},"NCT00446719","Safety and Antidepressant Effects of Rellidep in Major Depressive Disorder",[78,79],"2008-12","2007-08",23,[979],"Depression",[961],{"trials":982,"activeCount":88},[],{"trials":984,"activeCount":88},[],{"intervention":986,"totalTrials":84,"cells":987},"Tranexamic Acid Injectable Solution",{"EARLY_PHASE1":988,"PHASE1":990,"PHASE2":992,"PHASE3":994,"PHASE4":1006,"NA":1008},{"trials":989,"activeCount":88},[],{"trials":991,"activeCount":88},[],{"trials":993,"activeCount":88},[],{"trials":995,"activeCount":88},[996],{"nctId":997,"briefTitle":998,"status":446,"phases":999,"primaryCompletion":1000,"completion":1001,"start":1002,"enrollment":1003,"conditions":1004,"interventions":1005},"NCT03216083","Does Intravenous Tranexamic Acid Reduce Blood Loss During Vaginectomy?",[79],"2022-11","2022-12","2018-01-01",30,[700],[986],{"trials":1007,"activeCount":88},[],{"trials":1009,"activeCount":88},[],{"intervention":1011,"totalTrials":84,"cells":1012},"Metformin alone",{"EARLY_PHASE1":1013,"PHASE1":1015,"PHASE2":1017,"PHASE3":1019,"PHASE4":1032,"NA":1034},{"trials":1014,"activeCount":88},[],{"trials":1016,"activeCount":88},[],{"trials":1018,"activeCount":88},[],{"trials":1020,"activeCount":88},[1021],{"nctId":1022,"briefTitle":1023,"status":192,"phases":1024,"primaryCompletion":1025,"completion":1026,"start":1027,"enrollment":1028,"conditions":1029,"interventions":1030},"NCT02192424","Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)",[79],"2020-08","2020-09","2014-07",109,[15],[1011,1031],"Metformin + Intermittent Insulin Therapy",{"trials":1033,"activeCount":88},[],{"trials":1035,"activeCount":88},[],{"intervention":1031,"totalTrials":84,"cells":1037},{"EARLY_PHASE1":1038,"PHASE1":1040,"PHASE2":1042,"PHASE3":1044,"PHASE4":1050,"NA":1052},{"trials":1039,"activeCount":88},[],{"trials":1041,"activeCount":88},[],{"trials":1043,"activeCount":88},[],{"trials":1045,"activeCount":88},[1046],{"nctId":1022,"briefTitle":1023,"status":192,"phases":1047,"primaryCompletion":1025,"completion":1026,"start":1027,"enrollment":1028,"conditions":1048,"interventions":1049},[79],[15],[1011,1031],{"trials":1051,"activeCount":88},[],{"trials":1053,"activeCount":88},[],{"intervention":1055,"totalTrials":383,"cells":1056},"Botox",{"EARLY_PHASE1":1057,"PHASE1":1059,"PHASE2":1071,"PHASE3":1081,"PHASE4":1083,"NA":1085},{"trials":1058,"activeCount":88},[],{"trials":1060,"activeCount":88},[1061],{"nctId":1062,"briefTitle":1063,"status":192,"phases":1064,"primaryCompletion":1065,"completion":1065,"start":1066,"enrollment":1067,"conditions":1068,"interventions":1070},"NCT01832194","Use of Botox to Treat Scrotal Pain",[77],"2014-04","2013-03",20,[1069],"Scrotal Pain",[1055],{"trials":1072,"activeCount":88},[1073],{"nctId":1074,"briefTitle":1075,"status":192,"phases":1076,"primaryCompletion":1077,"completion":1077,"start":1078,"enrollment":916,"conditions":1079,"interventions":1080},"NCT02249234","Randomized Control Trial of the Use of Botox to Treat Chronic Scrotal Pain",[78],"2018-10","2014-08",[1069],[1055],{"trials":1082,"activeCount":88},[],{"trials":1084,"activeCount":88},[],{"trials":1086,"activeCount":88},[],{"intervention":1088,"totalTrials":84,"cells":1089},"Melatonin",{"EARLY_PHASE1":1090,"PHASE1":1092,"PHASE2":1094,"PHASE3":1107,"PHASE4":1109,"NA":1111},{"trials":1091,"activeCount":88},[],{"trials":1093,"activeCount":88},[],{"trials":1095,"activeCount":88},[1096],{"nctId":1097,"briefTitle":1098,"status":446,"phases":1099,"primaryCompletion":1100,"completion":1101,"start":1102,"enrollment":1103,"conditions":1104,"interventions":1106},"NCT02615340","Melatonin for Prevention of Delirium in Critically Ill Patients",[78],"2018-10-12","2019-10-12","2017-10-12",69,[1105],"Delirium",[1088],{"trials":1108,"activeCount":88},[],{"trials":1110,"activeCount":88},[],{"trials":1112,"activeCount":88},[],{"intervention":1114,"totalTrials":84,"cells":1115},"Nimodipine",{"EARLY_PHASE1":1116,"PHASE1":1118,"PHASE2":1120,"PHASE3":1131,"PHASE4":1133,"NA":1135},{"trials":1117,"activeCount":88},[],{"trials":1119,"activeCount":88},[],{"trials":1121,"activeCount":88},[1122],{"nctId":1123,"briefTitle":1124,"status":783,"phases":1125,"primaryCompletion":1065,"completion":1126,"start":1127,"enrollment":1128,"conditions":1129,"interventions":1130},"NCT01551368","Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients",[78],"2017-07","2012-12",12,[26],[1114],{"trials":1132,"activeCount":88},[],{"trials":1134,"activeCount":88},[],{"trials":1136,"activeCount":88},[],{"intervention":1138,"totalTrials":84,"cells":1139},"Vaginal progesterone",{"EARLY_PHASE1":1140,"PHASE1":1142,"PHASE2":1144,"PHASE3":1157,"PHASE4":1159,"NA":1161},{"trials":1141,"activeCount":88},[],{"trials":1143,"activeCount":88},[],{"trials":1145,"activeCount":88},[1146],{"nctId":1147,"briefTitle":1148,"status":558,"phases":1149,"primaryCompletion":1150,"start":1151,"enrollment":88,"conditions":1152,"interventions":1156},"NCT02460302","Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy",[78],"2020-12","2016-12",[1153,1154,1155],"Atrophic Vaginitis","Menopause","Vulvovaginal Atrophy",[1138],{"trials":1158,"activeCount":88},[],{"trials":1160,"activeCount":88},[],{"trials":1162,"activeCount":88},[],{"intervention":1164,"totalTrials":84,"cells":1165},"Metronidazole placebo",{"EARLY_PHASE1":1166,"PHASE1":1168,"PHASE2":1170,"PHASE3":1184,"PHASE4":1186,"NA":1188},{"trials":1167,"activeCount":88},[],{"trials":1169,"activeCount":88},[],{"trials":1171,"activeCount":88},[1172],{"nctId":1173,"briefTitle":1174,"status":783,"phases":1175,"primaryCompletion":1176,"completion":1176,"start":1177,"enrollment":1128,"conditions":1178,"interventions":1180},"NCT00257699","Study of Antibiotics in the Treatment of Colonic Crohn's Disease",[78],"2008-07","2006-05",[1179],"Crohn's Disease",[1164,1181,1182,1183],"ciprofloxacin placebo","ciprofloxacin","metronidazole",{"trials":1185,"activeCount":88},[],{"trials":1187,"activeCount":88},[],{"trials":1189,"activeCount":88},[],{"intervention":1181,"totalTrials":84,"cells":1191},{"EARLY_PHASE1":1192,"PHASE1":1194,"PHASE2":1196,"PHASE3":1202,"PHASE4":1204,"NA":1206},{"trials":1193,"activeCount":88},[],{"trials":1195,"activeCount":88},[],{"trials":1197,"activeCount":88},[1198],{"nctId":1173,"briefTitle":1174,"status":783,"phases":1199,"primaryCompletion":1176,"completion":1176,"start":1177,"enrollment":1128,"conditions":1200,"interventions":1201},[78],[1179],[1164,1181,1182,1183],{"trials":1203,"activeCount":88},[],{"trials":1205,"activeCount":88},[],{"trials":1207,"activeCount":88},[],{"intervention":1182,"totalTrials":84,"cells":1209},{"EARLY_PHASE1":1210,"PHASE1":1212,"PHASE2":1214,"PHASE3":1220,"PHASE4":1222,"NA":1224},{"trials":1211,"activeCount":88},[],{"trials":1213,"activeCount":88},[],{"trials":1215,"activeCount":88},[1216],{"nctId":1173,"briefTitle":1174,"status":783,"phases":1217,"primaryCompletion":1176,"completion":1176,"start":1177,"enrollment":1128,"conditions":1218,"interventions":1219},[78],[1179],[1164,1181,1182,1183],{"trials":1221,"activeCount":88},[],{"trials":1223,"activeCount":88},[],{"trials":1225,"activeCount":88},[],{"intervention":1183,"totalTrials":84,"cells":1227},{"EARLY_PHASE1":1228,"PHASE1":1230,"PHASE2":1232,"PHASE3":1238,"PHASE4":1240,"NA":1242},{"trials":1229,"activeCount":88},[],{"trials":1231,"activeCount":88},[],{"trials":1233,"activeCount":88},[1234],{"nctId":1173,"briefTitle":1174,"status":783,"phases":1235,"primaryCompletion":1176,"completion":1176,"start":1177,"enrollment":1128,"conditions":1236,"interventions":1237},[78],[1179],[1164,1181,1182,1183],{"trials":1239,"activeCount":88},[],{"trials":1241,"activeCount":88},[],{"trials":1243,"activeCount":88},[],{"intervention":1245,"totalTrials":84,"cells":1246},"Probiotic Lactobacilli",{"EARLY_PHASE1":1247,"PHASE1":1249,"PHASE2":1251,"PHASE3":1262,"PHASE4":1264,"NA":1266},{"trials":1248,"activeCount":88},[],{"trials":1250,"activeCount":88},[],{"trials":1252,"activeCount":88},[1253],{"nctId":1254,"briefTitle":1255,"status":192,"phases":1256,"primaryCompletion":485,"completion":485,"start":1257,"enrollment":1258,"conditions":1259,"interventions":1261},"NCT01697683","Probiotic Therapy for the Reversal of Bacterial Vaginosis in Pregnancy",[78],"2012-05",86,[1260],"Pregnant Women Who Test Positive for Bacterial Vaginosis",[1245],{"trials":1263,"activeCount":88},[],{"trials":1265,"activeCount":88},[],{"trials":1267,"activeCount":88},[],{"intervention":1269,"totalTrials":84,"cells":1270},"Fluzone High-Dose",{"EARLY_PHASE1":1271,"PHASE1":1273,"PHASE2":1275,"PHASE3":1287,"PHASE4":1289,"NA":1291},{"trials":1272,"activeCount":88},[],{"trials":1274,"activeCount":88},[],{"trials":1276,"activeCount":88},[1277],{"nctId":1278,"briefTitle":1279,"status":192,"phases":1280,"primaryCompletion":1281,"completion":1282,"start":536,"enrollment":1283,"conditions":1284,"interventions":1285},"NCT02263040","A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV",[77,78],"2016-07","2016-12-31",170,[29],[1269,1286],"Fluzone",{"trials":1288,"activeCount":88},[],{"trials":1290,"activeCount":88},[],{"trials":1292,"activeCount":88},[],{"intervention":1286,"totalTrials":84,"cells":1294},{"EARLY_PHASE1":1295,"PHASE1":1297,"PHASE2":1299,"PHASE3":1305,"PHASE4":1307,"NA":1309},{"trials":1296,"activeCount":88},[],{"trials":1298,"activeCount":88},[],{"trials":1300,"activeCount":88},[1301],{"nctId":1278,"briefTitle":1279,"status":192,"phases":1302,"primaryCompletion":1281,"completion":1282,"start":536,"enrollment":1283,"conditions":1303,"interventions":1304},[77,78],[29],[1269,1286],{"trials":1306,"activeCount":88},[],{"trials":1308,"activeCount":88},[],{"trials":1310,"activeCount":88},[],{"intervention":1312,"totalTrials":84,"cells":1313},"Intra-vitreal injection of bevacizumab",{"EARLY_PHASE1":1314,"PHASE1":1316,"PHASE2":1318,"PHASE3":1330,"PHASE4":1332,"NA":1334},{"trials":1315,"activeCount":88},[],{"trials":1317,"activeCount":88},[],{"trials":1319,"activeCount":88},[1320],{"nctId":1321,"briefTitle":1322,"status":446,"phases":1323,"primaryCompletion":1324,"completion":1324,"start":1325,"enrollment":1326,"conditions":1327,"interventions":1329},"NCT00813059","Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy",[78],"2012-06","2009-02",10,[1328],"Non-arteritic Anterior Ischemic Optic Neuropathy",[1312],{"trials":1331,"activeCount":88},[],{"trials":1333,"activeCount":88},[],{"trials":1335,"activeCount":88},[],{"intervention":1337,"totalTrials":84,"cells":1338},"Eucerin plus",{"EARLY_PHASE1":1339,"PHASE1":1341,"PHASE2":1343,"PHASE3":1355,"PHASE4":1357,"NA":1359},{"trials":1340,"activeCount":88},[],{"trials":1342,"activeCount":88},[],{"trials":1344,"activeCount":88},[1345],{"nctId":1346,"briefTitle":1347,"status":192,"phases":1348,"primaryCompletion":1349,"completion":1349,"start":1350,"enrollment":1351,"conditions":1352,"interventions":1353},"NCT00267111","Topical Amethocaine Gel for Intramuscular Injection in Term Neonates",[78],"2004-12","2003-07",110,[33],[1337,1354],"Amethocaine gel 4%",{"trials":1356,"activeCount":88},[],{"trials":1358,"activeCount":88},[],{"trials":1360,"activeCount":88},[],{"intervention":1354,"totalTrials":84,"cells":1362},{"EARLY_PHASE1":1363,"PHASE1":1365,"PHASE2":1367,"PHASE3":1373,"PHASE4":1375,"NA":1377},{"trials":1364,"activeCount":88},[],{"trials":1366,"activeCount":88},[],{"trials":1368,"activeCount":88},[1369],{"nctId":1346,"briefTitle":1347,"status":192,"phases":1370,"primaryCompletion":1349,"completion":1349,"start":1350,"enrollment":1351,"conditions":1371,"interventions":1372},[78],[33],[1337,1354],{"trials":1374,"activeCount":88},[],{"trials":1376,"activeCount":88},[],{"trials":1378,"activeCount":88},[],{"intervention":1380,"totalTrials":84,"cells":1381},"1% Lidocaine Paracervical Block",{"EARLY_PHASE1":1382,"PHASE1":1384,"PHASE2":1386,"PHASE3":1399,"PHASE4":1401,"NA":1403},{"trials":1383,"activeCount":88},[],{"trials":1385,"activeCount":88},[],{"trials":1387,"activeCount":88},[1388],{"nctId":1389,"briefTitle":1390,"status":192,"phases":1391,"primaryCompletion":1392,"completion":1392,"start":1393,"enrollment":1394,"conditions":1395,"interventions":1397},"NCT06532162","The PRICE Trial: Pain Reduction for Intrauterine Contraception Experiment",[78],"2024-08-16","2022-06-30",246,[1396],"Contraception",[1380,1398],"Normal Saline Paracervical",{"trials":1400,"activeCount":88},[],{"trials":1402,"activeCount":88},[],{"trials":1404,"activeCount":88},[],{"intervention":1398,"totalTrials":84,"cells":1406},{"EARLY_PHASE1":1407,"PHASE1":1409,"PHASE2":1411,"PHASE3":1417,"PHASE4":1419,"NA":1421},{"trials":1408,"activeCount":88},[],{"trials":1410,"activeCount":88},[],{"trials":1412,"activeCount":88},[1413],{"nctId":1389,"briefTitle":1390,"status":192,"phases":1414,"primaryCompletion":1392,"completion":1392,"start":1393,"enrollment":1394,"conditions":1415,"interventions":1416},[78],[1396],[1380,1398],{"trials":1418,"activeCount":88},[],{"trials":1420,"activeCount":88},[],{"trials":1422,"activeCount":88},[],{"intervention":1424,"totalTrials":84,"cells":1425},"Lactobacilli GR-1 and RC-14",{"EARLY_PHASE1":1426,"PHASE1":1428,"PHASE2":1439,"PHASE3":1441,"PHASE4":1443,"NA":1445},{"trials":1427,"activeCount":88},[],{"trials":1429,"activeCount":88},[1430],{"nctId":1431,"briefTitle":1432,"status":558,"phases":1433,"primaryCompletion":1434,"completion":1435,"start":586,"enrollment":88,"conditions":1436,"interventions":1438},"NCT00217308","Effect of Probiotic Lactobacilli on Vaginal Flora of Pregnant Women at High Risk for Preterm Delivery",[77],"2007-07","2007-09",[31,1437],"Bacterial Vaginosis",[1424],{"trials":1440,"activeCount":88},[],{"trials":1442,"activeCount":88},[],{"trials":1444,"activeCount":88},[],{"trials":1446,"activeCount":88},[],{"intervention":1448,"totalTrials":84,"cells":1449},"Sodium Nitroprusside",{"EARLY_PHASE1":1450,"PHASE1":1452,"PHASE2":1465,"PHASE3":1467,"PHASE4":1469,"NA":1471},{"trials":1451,"activeCount":88},[],{"trials":1453,"activeCount":88},[1454],{"nctId":1455,"briefTitle":1456,"status":446,"phases":1457,"primaryCompletion":1458,"completion":1458,"start":1257,"enrollment":1003,"conditions":1459,"interventions":1464},"NCT01619280","Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury",[77],"2013-06",[1460,1461,1448,1462,1463],"Acute Lung Injury","Acute Respiratory Distress Syndrome","Hypoxia","Respiratory Failure",[1448],{"trials":1466,"activeCount":88},[],{"trials":1468,"activeCount":88},[],{"trials":1470,"activeCount":88},[],{"trials":1472,"activeCount":88},[],{"intervention":1474,"totalTrials":383,"cells":1475},"Prometrium",{"EARLY_PHASE1":1476,"PHASE1":1478,"PHASE2":1480,"PHASE3":1491,"PHASE4":1493,"NA":1495},{"trials":1477,"activeCount":88},[],{"trials":1479,"activeCount":88},[],{"trials":1481,"activeCount":88},[1482],{"nctId":1483,"briefTitle":1484,"status":446,"phases":1485,"primaryCompletion":1151,"completion":1151,"start":1486,"enrollment":1487,"conditions":1488,"interventions":1490},"NCT02400021","Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals",[78],"2015-08",40,[1489],"HIV-1 Infection",[1474],{"trials":1492,"activeCount":88},[],{"trials":1494,"activeCount":88},[],{"trials":1496,"activeCount":88},[1497],{"nctId":1498,"briefTitle":1499,"status":446,"phases":1500,"primaryCompletion":1501,"completion":511,"start":1502,"enrollment":1503,"conditions":1504,"interventions":1506},"NCT03504345","Progesterone Supplementation in Frozen Embryo Transfer Cycles",[81],"2019-04","2018-05",240,[1505,26],"Infertility Due to Nonimplantation",[1474],{"intervention":1508,"totalTrials":383,"cells":1509},"Metformin",{"EARLY_PHASE1":1510,"PHASE1":1512,"PHASE2":1514,"PHASE3":1516,"PHASE4":1527,"NA":1529},{"trials":1511,"activeCount":88},[],{"trials":1513,"activeCount":88},[],{"trials":1515,"activeCount":88},[],{"trials":1517,"activeCount":88},[1518],{"nctId":1519,"briefTitle":1520,"status":192,"phases":1521,"primaryCompletion":1522,"completion":1522,"start":1523,"enrollment":1524,"conditions":1525,"interventions":1526},"NCT01353391","Metformin in Women With Type 2 Diabetes in Pregnancy Trial",[79],"2019-06-05","2011-05-25",500,[15],[1508],{"trials":1528,"activeCount":88},[],{"trials":1530,"activeCount":88},[1531],{"nctId":1532,"briefTitle":1533,"status":192,"phases":1534,"primaryCompletion":561,"completion":561,"start":397,"enrollment":1535,"conditions":1536,"interventions":1537},"NCT00897884","Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer",[81],39,[400],[1508],{"intervention":1539,"totalTrials":383,"cells":1540},"Hydromorphone",{"EARLY_PHASE1":1541,"PHASE1":1543,"PHASE2":1545,"PHASE3":1547,"PHASE4":1549,"NA":1551},{"trials":1542,"activeCount":88},[],{"trials":1544,"activeCount":88},[],{"trials":1546,"activeCount":88},[],{"trials":1548,"activeCount":88},[],{"trials":1550,"activeCount":88},[],{"trials":1552,"activeCount":88},[1553,1564],{"nctId":1554,"briefTitle":1555,"status":446,"phases":1556,"primaryCompletion":1557,"completion":1557,"start":1558,"enrollment":654,"conditions":1559,"interventions":1560},"NCT02880800","Does IVPCA Increase Opioid Consumption and Side Effects in Fast Track Orthopedic Procedures?",[81],"2017-08","2016-08",[514],[1561,1562,1563,1539],"Morphine as IVPCA","Hydromorphone as IVPCA","Morphine",{"nctId":1565,"briefTitle":1566,"status":783,"phases":1567,"primaryCompletion":1568,"completion":1568,"start":1569,"enrollment":24,"conditions":1570,"interventions":1572},"NCT03478423","Opioid Analgesics for Acute Fracture Pain in Adults Discharged From the ED",[81],"2019-09-17","2018-02-05",[1571],"Acute Pain",[1573,1574,1539],"Codeine","Oxycodone",{"intervention":1576,"totalTrials":84,"cells":1577},"2% aqueous chlorhexidine",{"EARLY_PHASE1":1578,"PHASE1":1580,"PHASE2":1582,"PHASE3":1584,"PHASE4":1586,"NA":1588},{"trials":1579,"activeCount":88},[],{"trials":1581,"activeCount":88},[],{"trials":1583,"activeCount":88},[],{"trials":1585,"activeCount":88},[],{"trials":1587,"activeCount":88},[],{"trials":1589,"activeCount":88},[1590],{"nctId":1591,"briefTitle":1592,"status":446,"phases":1593,"primaryCompletion":484,"completion":484,"start":474,"enrollment":1594,"conditions":1595,"interventions":1597},"NCT01270776","Efficacy Study Comparing 2% Chlorhexidine in 70% Isopropyl Alcohol Versus 2% Aqueous Chlorhexidine",[81],462,[1596],"Anti-infecting Agents, Local",[1576,1598],"2% Chlorhexidine 70% isopropyl alcohol",{"intervention":1598,"totalTrials":84,"cells":1600},{"EARLY_PHASE1":1601,"PHASE1":1603,"PHASE2":1605,"PHASE3":1607,"PHASE4":1609,"NA":1611},{"trials":1602,"activeCount":88},[],{"trials":1604,"activeCount":88},[],{"trials":1606,"activeCount":88},[],{"trials":1608,"activeCount":88},[],{"trials":1610,"activeCount":88},[],{"trials":1612,"activeCount":88},[1613],{"nctId":1591,"briefTitle":1592,"status":446,"phases":1614,"primaryCompletion":484,"completion":484,"start":474,"enrollment":1594,"conditions":1615,"interventions":1616},[81],[1596],[1576,1598],{"intervention":1618,"totalTrials":84,"cells":1619},"Genomic analysis",{"EARLY_PHASE1":1620,"PHASE1":1622,"PHASE2":1624,"PHASE3":1626,"PHASE4":1628,"NA":1630},{"trials":1621,"activeCount":88},[],{"trials":1623,"activeCount":88},[],{"trials":1625,"activeCount":88},[],{"trials":1627,"activeCount":88},[],{"trials":1629,"activeCount":88},[],{"trials":1631,"activeCount":88},[1632],{"nctId":1633,"briefTitle":1634,"status":192,"phases":1635,"primaryCompletion":1636,"completion":1636,"start":1637,"enrollment":475,"conditions":1638,"interventions":1642},"NCT05402579","Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk",[],"2025-01-20","2022-07-29",[1639,1640,1641],"Diabetes Type 2","DKA","Diabetic Ketoacidosis",[1618],{"intervention":1561,"totalTrials":84,"cells":1644},{"EARLY_PHASE1":1645,"PHASE1":1647,"PHASE2":1649,"PHASE3":1651,"PHASE4":1653,"NA":1655},{"trials":1646,"activeCount":88},[],{"trials":1648,"activeCount":88},[],{"trials":1650,"activeCount":88},[],{"trials":1652,"activeCount":88},[],{"trials":1654,"activeCount":88},[],{"trials":1656,"activeCount":88},[1657],{"nctId":1554,"briefTitle":1555,"status":446,"phases":1658,"primaryCompletion":1557,"completion":1557,"start":1558,"enrollment":654,"conditions":1659,"interventions":1660},[81],[514],[1561,1562,1563,1539],{"intervention":1562,"totalTrials":84,"cells":1662},{"EARLY_PHASE1":1663,"PHASE1":1665,"PHASE2":1667,"PHASE3":1669,"PHASE4":1671,"NA":1673},{"trials":1664,"activeCount":88},[],{"trials":1666,"activeCount":88},[],{"trials":1668,"activeCount":88},[],{"trials":1670,"activeCount":88},[],{"trials":1672,"activeCount":88},[],{"trials":1674,"activeCount":88},[1675],{"nctId":1554,"briefTitle":1555,"status":446,"phases":1676,"primaryCompletion":1557,"completion":1557,"start":1558,"enrollment":654,"conditions":1677,"interventions":1678},[81],[514],[1561,1562,1563,1539],{"intervention":1563,"totalTrials":84,"cells":1680},{"EARLY_PHASE1":1681,"PHASE1":1683,"PHASE2":1685,"PHASE3":1687,"PHASE4":1689,"NA":1691},{"trials":1682,"activeCount":88},[],{"trials":1684,"activeCount":88},[],{"trials":1686,"activeCount":88},[],{"trials":1688,"activeCount":88},[],{"trials":1690,"activeCount":88},[],{"trials":1692,"activeCount":88},[1693],{"nctId":1554,"briefTitle":1555,"status":446,"phases":1694,"primaryCompletion":1557,"completion":1557,"start":1558,"enrollment":654,"conditions":1695,"interventions":1696},[81],[514],[1561,1562,1563,1539],{"intervention":1698,"totalTrials":84,"cells":1699},"Ringer's Lactate",{"EARLY_PHASE1":1700,"PHASE1":1702,"PHASE2":1704,"PHASE3":1706,"PHASE4":1708,"NA":1710},{"trials":1701,"activeCount":88},[],{"trials":1703,"activeCount":88},[],{"trials":1705,"activeCount":88},[],{"trials":1707,"activeCount":88},[],{"trials":1709,"activeCount":88},[],{"trials":1711,"activeCount":88},[1712],{"nctId":1713,"briefTitle":1714,"status":192,"phases":1715,"primaryCompletion":1716,"completion":1716,"start":1717,"enrollment":1487,"conditions":1718,"interventions":1720},"NCT05424510","PoCUS Guided Fluids to Prevent Post-induction Hypotension",[81],"2023-02-22","2022-07-05",[1719],"Hypotension on Induction",[1698],{"intervention":1722,"totalTrials":84,"cells":1723},"Inhaled Beclomethasone Dipropionate Monohydrate",{"EARLY_PHASE1":1724,"PHASE1":1726,"PHASE2":1728,"PHASE3":1730,"PHASE4":1732,"NA":1734},{"trials":1725,"activeCount":88},[],{"trials":1727,"activeCount":88},[],{"trials":1729,"activeCount":88},[],{"trials":1731,"activeCount":88},[],{"trials":1733,"activeCount":88},[],{"trials":1735,"activeCount":88},[1736],{"nctId":1737,"briefTitle":1738,"status":192,"phases":1739,"primaryCompletion":1740,"completion":1740,"start":1741,"enrollment":1742,"conditions":1743,"interventions":1745},"NCT03503994","Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia",[81],"2006-11-15","2001-07-27",41,[1744],"Bronchopulmonary Dysplasia",[1722],{"intervention":1747,"totalTrials":84,"cells":1748},"Low molecular weight heparin and low dose aspirin",{"EARLY_PHASE1":1749,"PHASE1":1751,"PHASE2":1753,"PHASE3":1755,"PHASE4":1757,"NA":1759},{"trials":1750,"activeCount":88},[],{"trials":1752,"activeCount":88},[],{"trials":1754,"activeCount":88},[],{"trials":1756,"activeCount":88},[],{"trials":1758,"activeCount":88},[],{"trials":1760,"activeCount":88},[1761],{"nctId":1762,"briefTitle":1763,"status":783,"phases":1764,"completion":1765,"start":1766,"enrollment":1767,"conditions":1768,"interventions":1771},"NCT00564174","Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT",[81],"2005-09","2000-03",88,[1769,1770],"Recurrent Pregnancy Loss","Antiphospholipid Antibody Syndrome",[1747,1772],"Low dose aspirin",{"intervention":1772,"totalTrials":84,"cells":1774},{"EARLY_PHASE1":1775,"PHASE1":1777,"PHASE2":1779,"PHASE3":1781,"PHASE4":1783,"NA":1785},{"trials":1776,"activeCount":88},[],{"trials":1778,"activeCount":88},[],{"trials":1780,"activeCount":88},[],{"trials":1782,"activeCount":88},[],{"trials":1784,"activeCount":88},[],{"trials":1786,"activeCount":88},[1787],{"nctId":1762,"briefTitle":1763,"status":783,"phases":1788,"completion":1765,"start":1766,"enrollment":1767,"conditions":1789,"interventions":1790},[81],[1769,1770],[1747,1772],{"intervention":1792,"totalTrials":84,"cells":1793},"Lidocaine 1% Injectable Solution",{"EARLY_PHASE1":1794,"PHASE1":1796,"PHASE2":1798,"PHASE3":1800,"PHASE4":1802,"NA":1804},{"trials":1795,"activeCount":88},[],{"trials":1797,"activeCount":88},[],{"trials":1799,"activeCount":88},[],{"trials":1801,"activeCount":88},[],{"trials":1803,"activeCount":88},[],{"trials":1805,"activeCount":88},[1806],{"nctId":1807,"briefTitle":1808,"status":192,"phases":1809,"primaryCompletion":1810,"completion":1810,"start":1811,"enrollment":1812,"conditions":1813,"interventions":1814},"NCT06546254","1% Lidocaine Paracervical Block for Endometrial Biopsy",[81],"2026-01-22","2025-06-19",96,[378],[1792],{"intervention":1573,"totalTrials":84,"cells":1816},{"EARLY_PHASE1":1817,"PHASE1":1819,"PHASE2":1821,"PHASE3":1823,"PHASE4":1825,"NA":1827},{"trials":1818,"activeCount":88},[],{"trials":1820,"activeCount":88},[],{"trials":1822,"activeCount":88},[],{"trials":1824,"activeCount":88},[],{"trials":1826,"activeCount":88},[],{"trials":1828,"activeCount":88},[1829],{"nctId":1565,"briefTitle":1566,"status":783,"phases":1830,"primaryCompletion":1568,"completion":1568,"start":1569,"enrollment":24,"conditions":1831,"interventions":1832},[81],[1571],[1573,1574,1539],{"intervention":1574,"totalTrials":84,"cells":1834},{"EARLY_PHASE1":1835,"PHASE1":1837,"PHASE2":1839,"PHASE3":1841,"PHASE4":1843,"NA":1845},{"trials":1836,"activeCount":88},[],{"trials":1838,"activeCount":88},[],{"trials":1840,"activeCount":88},[],{"trials":1842,"activeCount":88},[],{"trials":1844,"activeCount":88},[],{"trials":1846,"activeCount":88},[1847],{"nctId":1565,"briefTitle":1566,"status":783,"phases":1848,"primaryCompletion":1568,"completion":1568,"start":1569,"enrollment":24,"conditions":1849,"interventions":1850},[81],[1571],[1573,1574,1539],{"intervention":1852,"totalTrials":84,"cells":1853},"metoclopramide",{"EARLY_PHASE1":1854,"PHASE1":1856,"PHASE2":1858,"PHASE3":1860,"PHASE4":1862,"NA":1864},{"trials":1855,"activeCount":88},[],{"trials":1857,"activeCount":88},[],{"trials":1859,"activeCount":88},[],{"trials":1861,"activeCount":88},[],{"trials":1863,"activeCount":88},[],{"trials":1865,"activeCount":88},[1866],{"nctId":1867,"briefTitle":1868,"status":558,"phases":1869,"primaryCompletion":1870,"completion":1870,"start":411,"enrollment":88,"conditions":1871,"interventions":1874},"NCT02262923","Dopamine D-2 Antagonist Use in Poor Responders in IVF: a Randomized Controlled Trial",[81],"2018-03",[1872,1873],"in Vitro Fertilization","Poor Responder",[1852],{"intervention":1876,"totalTrials":84,"cells":1877},"Prophylactic low molecular weight heparin",{"EARLY_PHASE1":1878,"PHASE1":1880,"PHASE2":1882,"PHASE3":1884,"PHASE4":1886,"NA":1888},{"trials":1879,"activeCount":88},[],{"trials":1881,"activeCount":88},[],{"trials":1883,"activeCount":88},[],{"trials":1885,"activeCount":88},[],{"trials":1887,"activeCount":88},[],{"trials":1889,"activeCount":88},[1890],{"nctId":1891,"briefTitle":1892,"status":192,"phases":1893,"primaryCompletion":1894,"completion":1895,"start":1896,"enrollment":1003,"conditions":1897,"interventions":1899},"NCT05058924","Low Molecular Weight hEparin vs. Aspirin Post-partum",[81],"2024-02-29","2024-03-01","2021-08-29",[1898],"Venous Thromboembolism",[1876,1900],"Low molecular weight heparin and low-dose aspirin",{"intervention":1900,"totalTrials":84,"cells":1902},{"EARLY_PHASE1":1903,"PHASE1":1905,"PHASE2":1907,"PHASE3":1909,"PHASE4":1911,"NA":1913},{"trials":1904,"activeCount":88},[],{"trials":1906,"activeCount":88},[],{"trials":1908,"activeCount":88},[],{"trials":1910,"activeCount":88},[],{"trials":1912,"activeCount":88},[],{"trials":1914,"activeCount":88},[1915],{"nctId":1891,"briefTitle":1892,"status":192,"phases":1916,"primaryCompletion":1894,"completion":1895,"start":1896,"enrollment":1003,"conditions":1917,"interventions":1918},[81],[1898],[1876,1900]]